Aravive (NASDAQ:ARAV) reported quarterly losses of $(0.53) per share. This is a 19.7 percent increase over losses of $(0.66) per share from the same period last year.
Stifel Maintains Buy on Sonendo, Lowers Price Target to $6
Stifel analyst Jonathan Block maintains Sonendo (NYSE:SONX) with a Buy and lowers the price target from $10 to $6.